1,119
Views
3
CrossRef citations to date
0
Altmetric
Drug safety evaluation

Evaluating safety in hyaluronic acid lip injections

ORCID Icon, , &
Pages 1473-1486 | Received 16 May 2021, Accepted 27 Jul 2021, Published online: 19 Aug 2021

References

  • [cited 1 June 2021]. Available from: https://www.plasticsurgery.org/documents/News/Statistics/2019/plastic-surgery-statistics-full-report-2019.pdf
  • Swift A, Remington K. BeautiPHIcation™: a global approach to facial beauty. Clin Plast Surg. 2011 July;38(3):347–77, v. PMID: 21824535.
  • [cited 1 June 2021]. Available from: https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers
  • Hirsch P, Infanger M, Kraus A. A case of upper lip necrosis after cosmetic injection of hyaluronic acid soft-tissue filler-Does capillary infarction play a role in the development of vascular compromise, and what are the implications? J Cosmet Dermatol. 2020 June;19(6):1316–1320. Epub 2020 Apr 8. PMID: 32270567.
  • Stojanovič L, Majdič N. Effectiveness and safety of hyaluronic acid fillers used to enhance overall lip fullness: a systematic review of clinical studies. J Cosmet Dermatol. 2019 Apr;18(2):436–443. Epub 2019 Jan 12. PMID: 30636365.
  • Rayess HM, Svider PF, Hanba C, et al. A cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg. 2018 May 1;20(3):207–214. PMID: 29270603; PMCID: PMC6145786.
  • Dayan S, Bruce S, Kilmer S, et al. Safety and effectiveness of the hyaluronic acid filler, HYC‐24L, for lip and perioral augmentation. Dermatol Surg. 2015;41(Suppl 1):S293–301.
  • Downie J, Mao Z, Rachel Lo T‐W, et al. A double‐blind, clinical evaluation of facial augmentation treatments: a comparison of PRI 1, PRI 2, Zyplast and Perlane. J Plast Reconstr Aesthet Surg. 2009;62:1636–1643.
  • Carruthers A, Carey W, De Lorenzi C, et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005 Nov;31(11 Pt 2):1591–8; discussion 1598. PMID: 16416643.
  • Solish N, Swift A. An open-label, pilot study to assess the effectiveness and safety of hyaluronic acid gel in the restoration of soft tissue fullness of the lips. J Drugs Dermatol. 2011 Feb;10(2):145–149. PMID: 21283918.
  • Solomon P, Sklar M, Zener R. Facial soft tissue augmentation with Artecoll(®): a review of eight years of clinical experience in 153 patients. Can J Plast Surg. 2012 Spring;20(1):28–32. PMID: 23598763; PMCID: PMC3307678.
  • Geronemus RG, Bank DE, Hardas B, et al. Safety and effectiveness of VYC-15L, a hyaluronic acid filler for lip and perioral enhancement: one-year results from a randomized, controlled study. Dermatol Surg. 2017 Mar;43(3):396–404. PMID: 28157728.
  • Hilton S, Sattler G, Berg AK, et al. Randomized, evaluator-blinded study comparing safety and effect of two hyaluronic acid gels for lips enhancement. Dermatol Surg. 2018 Feb;44(2):261–269. PMID: 29059146; PMCID: PMC5821480.
  • Yazdanparast T, Samadi A, Hasanzadeh H, et al. Assessment of the efficacy and safety of hyaluronic acid gel injection in the restoration of fullness of the upper lips. J Cutan Aesthet Surg. 2017 Apr–June;10(2):101–105. PMID: 28852297; PMCID: PMC5561704.
  • Artzi O, Loizides C, Verner I, et al. Resistant and recurrent late reaction to hyaluronic acid-based gel. Dermatol Surg. 2016 Jan;42(1):31–37. PMID: 26655699.
  • Beer K, Glogau RG, Dover JS, et al. A randomized, evaluator‐ blinded, controlled study of effectiveness and safety of small parti‐ cle hyaluronic acid plus lidocaine for lip augmentation and perioral rhytides. Dermatol Surg. 2015;41(Suppl 1):S127–S136.
  • Raspaldo H, Chantrey J, Belhaouari L, et al. Juvéderm volbella with lidocaine for lip and perioral enhancement: a prospective, randomized, controlled trial. Plast Reconstr Surg Glob Open. 2015 Apr 7;3(3):e321. PMID: 25878932; PMCID: PMC4387143.
  • Fagien S, Maas C, Murphy DK, et al. Juvéderm Lips Study Group. Juvederm ultra for lip enhancement: an open-label, multicenter study. Aesthet Surg J. 2013 Mar;33(3):414–420. PMID: 23515385.
  • Eccleston D, Murphy DK. Juvéderm(®) Volbella™ in the perioral area: a 12-month prospective, multicenter, open-label study. Clin Cosmet Investig Dermatol. 2012;5:167–172. Epub 2012 Oct 26. PMID: 23152693; PMCID: PMC3496328.
  • Glogau RG, Bank D, Brandt F, et al. A randomized, evaluator-blinded, controlled study of the effectiveness and safety of small gel particle hyaluronic acid for lip augmentation. Dermatol Surg. 2012 July;38(7 Pt 2):1180–1192. PMID: 22759255.
  • Taylor SC, Downie JB, Shamban A, et al. Lip and perioral enhancement with hyaluronic acid dermal fillers in individuals with skin of color. Dermatol Surg. 2019 July;45(7):959–967. PMID: 30789512.
  • Chopra R, Graivier M, Fabi S, et al. A multi-center, open-label, prospective study of cannula injection of small-particle hyaluronic acid plus lidocaine (SPHAL) for lip augmentation. J Drugs Dermatol. 2018 Jan 1;17:10–16. PMID: 29320583.
  • Samuelson U, Fagrell D, Wetter A, et al. An open-label, multicenter, evaluator-blinded study to assess the efficacy and safety of a new hyaluronic acid-based gel product for lip enhancement. Dermatol Surg. 2015 Sept;41(9):1052–1059. PMID: 26230331.
  • Fischer TC, Sattler G, Gauglitz GG. Hyaluronic acid filler containing lidocaine on a CPM basis for lip augmentation: reports from practical experience. Facial Plast Surg. 2015;32(3):283–288.
  • Rivkin A, Weinkle SH, Hardas B, et al. Safety and effectiveness of repeat treatment with VYC-15L for lip and perioral enhancement: results from a prospective multicenter study. Aesthet Surg J. 2019 Mar 14;39(4):413–422. PMID: 29506034; PMCID: PMC6416707.
  • Bertucci V, Nikolis A, Solish N, et al. Efficacy and safety of flexible hyaluronic acid fillers in lip and perioral enhancement. J Drugs Dermatol. 2021 Apr 1;20(4):402–408. PMID: 33852235.
  • Philipp-Dormston WG, Hilton S, Nathan M. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips. J Cosmet Dermatol. 2014 June;13(2):125–134. PMID: 24910276; PMCID: PMC4141748.
  • Weiss R, Beer K, Cox SE, et al. A randomized, controlled, evaluator-blinded, multi-center study of hyaluronic acid filler effectiveness and safety in lip fullness augmentation. Dermatol Surg. 2021 Apr 1;47(4):527–532. PMID: 33587369; PMCID: PMC8021234.
  • Schenck TL, Koban KC, Schlattau A, et al. Updated anatomy of the buccal space and its implications for plastic, reconstructive and aesthetic procedures. J Plast Reconstr Aesthet Surg. 2018 Feb;71(2):162–170. Epub 2017 Dec 8. PMID: 29233508.
  • Cotofana S, Pretterklieber B, Lucius R, et al. Distribution Pattern of the Superior and Inferior Labial Arteries: impact for Safe Upper and Lower Lip Augmentation Procedures. Plast Reconstr Surg. 2017 May;139(5):1075–1082. PMID: 28092335.
  • Cotofana S, Alfertshofer M, Schenck TL, et al. Anatomy of the superior and inferior labial arteries revised: an ultrasound investigation and implication for lip volumization. Aesthet Surg J. 2020 Nov 19;40(12):1327–1335. PMID: 32469050.
  • Galadari H, Mariwalla K, Delobel P, et al. Pain and bruising levels after lip augmentation: a comparison of anterograde and retrograde techniques using an automated motorized injection device. a blinded, prospective, randomized, parallel within-subject trial. Dermatol Surg. 2020 Mar;46(3):395–401. PMID: 31453902.
  • Pavicic T, Frank K, Erlbacher K, et al. Precision in dermal filling: a comparison between needle and cannula when using soft tissue fillers. J Drugs Dermatol. 2017 Sept 1;16:866–872. PMID: 28915281.
  • Yomtoob DE, Dewan MA, Lee MS, et al. Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections. Ophthalmic Plast Reconstr Surg. 2009 Sep-Oct;25(5):376–377. PMID: 19966651.
  • Shah NS, Lazarus MC, Bugdodel R, et al. The ef- fects of topical vitamin K on bruising after laser treat- ment. J Am Acad Dermatol. 2002;47(2):241–244.
  • Fitzgerald R, Bertucci V, Sykes JM, et al. Adverse re- actions to injectable fillers. Facial Plast Surg. 2016;32(5):532–555.
  • Urdiales-Gálvez F, Delgado NE, Figueiredo V, et al. Treatment of soft tissue filler complications: expert consensus recommendations. Aesthetic Plast Surg. 2018 Apr;42(2):498–510. Epub 2018 Jan 5. PMID: 29305643; PMCID: PMC5840246.
  • King M. The management of bruising following nonsurgical cosmetic treatment. J Clin Aesthet Dermatol. 2017 Feb;10(2):E1–E4. Epub 2017 Feb 1. PMID: 28367264; PMCID: PMC5367875.
  • Nestor MS, Ablon GR, Stillman MA. The use of a contact cooling device to reduce pain and ecchymosis associated with dermal filler injections. J Clin Aesthet Dermatol. 2010 Mar;3(3):29–34. PMID: 20725541; PMCID: PMC2921743.
  • King M. Management of Edema. J Clin Aesthet Dermatol. 2017 Jan;10(1):E1–E4. Epub 2017 Jan 1. PMID: 28210383; PMCID: PMC5300735.
  • Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013 Dec 12;6:295–316. PMID: 24363560; PMCID: PMC3865975.
  • Bhojani-Lynch T. Late-onset inflammatory response to hyaluronic acid dermal fillers. Plast Reconstr Surg Glob Open. 2017 Dec 22;5(12):e1532. PMID: 29632758; PMCID: PMC5889432.
  • Hirsch RJ, Narurkar V, Carruthers J. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med. 2006 Mar;38(3):202–204. PMID: 16485276.
  • Wagner RD, Fakhro A, Cox JA, et al. Etiology, prevention, and management of infectious complications of dermal fillers. Semin Plast Surg. 2016 May;30(2):83–86. PMID: 27152101; PMCID: PMC4856531.
  • Marusza W, Olszanski R, Sierdzinski J, et al. Treatment of late bacterial infections resulting from soft-tissue filler injections. Infect Drug Resist. 2019 Feb 20;12:469–480. PMID: 30863129; PMCID: PMC6390860.
  • Philipp-Dormston WG, Goodman GJ, De Boulle K, et al. Global approaches to the prevention and management of delayed-onset adverse reactions with hyaluronic acid-based fillers. Plast Reconstr Surg Glob Open. 2020 Apr 29;8(4):e2730. PMID: 32440404; PMCID: PMC7209845.
  • Fitzgerald R, Bertucci V, Sykes JM, et al. Adverse reactions to injectable fillers. Facial Plast Surg. 2016 Oct;32(5):532–555. Epub 2016 Sep 28. PMID: 27680525.
  • Rohrich RJ, Monheit G, Nguyen AT, et al. Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg. 2010 Apr;125(4):1250–1256. Erratum in: Plast Reconstr Surg. 2010 Jun;125(6):1850.PMID: 19935452.
  • Cecchi R, Spota A, Frati P, et al. Migrating granulomatous chronic reaction from hyaluronic acid skin filler (Restylane): review and histopathological study with histochemical stainings. Dermatology. 2014;228(1):14–17. Epub 2013 Dec 17. PMID: 24356179.
  • Beer K, Downie J, Beer J. A treatment protocol for vascular occlusion from particulate soft tissue augmentation. J Clin Aesthet Dermatol. 2012 May;5(5):44–47. PMID: 22808309; PMCID: PMC3366448.
  • Wang C, Sun T, Yu N, et al. Herpes reactivation after the injection of hyaluronic acid dermal filler: a case report and review of literature. Medicine (Baltimore). 2020 June 12;99(24):e20394. PMID: 32541459; PMCID: PMC7302668.
  • Abtahi-Naeini B, Faghihi G, Shahmoradi Z, et al. Filler migration and extensive lesions after lip augmentation: adverse effects of polydimethylsiloxane filler. J Cosmet Dermatol. 2018 Dec;17(6):996–999. Epub 2018 Jan 7. PMID: 29316184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.